| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |